Clinical Trial Update: Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing liposomal irinotecan with oxaliplatin and S-1 versus gemcitabine with capecitabine as postoperative adjuvant therapy for pancreatic canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)
• Onivyde (irinotecan hydrochloride liposome injection)
• S-1 (tegafur/gimeracil/oteracil)
• Xeloda (capecitabine)

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Pancreatic Cancer | Phase 3 | Status: NOT_YET_RECRUITING